Chang; Lehua

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chang; Lehua.The latest application filed is for "substituted triazolo bicyclic compounds as pde2 inhibitors".

Company Profile

4.24.20

Chang; Lehua - Ramsey NJ US
Chang; Lehua - Rahway NJ US
- Ramsey NJ US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors Grant 10,647,727 - Morriello , et al.	2020-05-12
Substituted triazolo bicyclic compounds as PDE2 inhibitors Grant 10,357,481 - Morriello , et al. July 23, 2	2019-07-23
Piperazine derivatives as HIV protease inhibitors Grant 10,138,255 - Williams , et al. Nov	2018-11-27
Substituted Triazolo Bicyclic Compounds As Pde2 Inhibitors App 20180169072 - MORRIELLO; Gregori J. ; et al.	2018-06-21
Substituted Pyrazolo/imidazolo Bicyclic Compounds As Pde2 Inhibitors App 20180162874 - Morriello; Gregori J. ; et al.	2018-06-14
Piperazine derivatives as HIV protease inhibitors Grant 9,840,478 - Williams , et al. December 12, 2	2017-12-12
Piperazine Derivatives As Hiv Protease Inhibitors App 20170073354 - Williams; Peter D. ; et al.	2017-03-16
Piperazine Derivatives As Hiv Protease Inhibitors App 20160159752 - Williams; Peter D. ; et al.	2016-06-09
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment Grant 8,957,062 - Edmondson , et al. February 17, 2	2015-02-17
Pyrrolidine derived .beta.3 adrenergic receptor agonists Grant 8,933,102 - Morriello , et al. January 13, 2	2015-01-13
Substituted Cycloproply Compounds, Compositions Containing Such Compounds And Methods Of Treatment App 20140057893 - Edmondson; Scott ; et al.	2014-02-27
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists Grant 8,653,260 - Berger , et al. February 18, 2	2014-02-18
Pyrrolidine-derived beta 3 adrenergic receptor agonists Grant 08618144 -	2013-12-31
Pyrrolidine-derived beta 3 adrenergic receptor agonists Grant 8,618,144 - Lin , et al. December 31, 2	2013-12-31
Pyrrolidine derived beta 3 adrenergic receptor agonists Grant 8,604,038 - Edmondson , et al. December 10, 2	2013-12-10
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20130225599 - Morriello; Gregori J. ; et al.	2013-08-29
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists Grant 8,501,786 - Berger , et al. August 6, 2	2013-08-06
Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists Grant 8,399,480 - Berger , et al. March 19, 2	2013-03-19
Pyrrolidine derived beta 3 adrenergic receptor agonists Grant 8,354,403 - Edmondson , et al. January 15, 2	2013-01-15
Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists App 20120258963 - Berger; Richard ; et al.	2012-10-11
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20120225886 - Edmondson; Scott D. ; et al.	2012-09-06
Hydroxymethyl pyrrolidines as .beta.3 adrenergic receptor agonists Grant 8,247,415 - Berger , et al. August 21, 2	2012-08-21
Novel Pyrrolidine Derived Beta 3 Adrenergic Receptor Agonists App 20120157432 - Edmondson; Scott D. ; et al.	2012-06-21
Pyrrolidine-derived Beta 3 Adrenergic Receptor Agonists App 20120053181 - Lin; Peter ; et al.	2012-03-01
Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists App 20110028461 - Berger; Richard ; et al.	2011-02-03
Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists App 20110028481 - Berger; Richard ; et al.	2011-02-03
Hydroxymethyl Pyrrolidines As Beta 3 Adrenergic Receptor Agonists App 20090253705 - Berger; Richard ; et al.	2009-10-08
2-Aminoquinoline compounds Grant 7,084,156 - DeVita , et al. August 1, 2	2006-08-01
2-Aminoquinoline compounds App 20050026915 - DeVita, Robert J. ; et al.	2005-02-03
4-Aminoquinoline compounds App 20050009815 - DeVita, Robert J. ; et al.	2005-01-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.